Columnist Desiree Lama has accepted her MS diagnosis as part of her identity — but it's not the only thing that defines her, ...

The totality of data from Sanofi clinical trials indicates that Tolebrutinib may target inflammation thought to contribute to ...

Five years of continuous Briumvi kept MS relapse rates and disability progression low, according to analyses from a trial's ...

High-dose cholecalciferol (vitamin D) is safe and can nearly double the time it takes for clinically isolated syndrome to ...

A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...

The online program "Eating Well with MS" improved dietary behavior among multiple sclerosis patients and was deemed valuable, ...

Communicating my experience with MS is important, columnist Ben Hofmeister says, but so is making sure the other person comprehends it.

The U.S. Food and Drug Administration (FDA) has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq), a subcutaneous, or under-the-skin, formulation of Ocrevus (ocrelizumab), for treating ...

I’ve been trying to improve my health through lifestyle changes, which I hope will have a positive effect on my multiple sclerosis (MS). In an earlier column, I discussed my struggles to eat a ...

As I write this, I feel mentally, physically, and emotionally well — something I always take advantage of before my health goes downhill, as it will sometimes. The only issue I struggle with in ...